PharmiWeb.com - Global Pharma News & Resources
21-Dec-2023

Verisante Technology, Inc. Announces 2023 AGM Results

VANCOUVER, BC / ACCESSWIRE / December 20, 2023 / Verisante Technology, Inc. (TSXV:VER.H) (the "Company") is pleased to announce that at the 2023 Annual General Meeting held on December 18, 2023, in Vancouver, British Columbia, the Company's shareholders voted in favour of all items of business. All director nominees were elected.

The shareholders approved resolutions to set the number of directors at four, and to elect Thomas Braun, Jake Thiessen, Emmeline Braun and Vincent Trinh to serve as directors until the next annual meeting or until their respective successors are duly elected and qualified.

The shareholders also voted to accept the audited financial statements for the year ended December 31, 2022 and ratified the re-appointment of the Company's auditors, Fernandez Young, LLP, as auditors of the Company for the year ended December 31, 2023.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Company Contact:

Thomas Braun, President & CEO
Verisante Technology, Inc.
Telephone: (604) 716-5133
Email: info@verisante.com

Forward Looking Statements:

This news release may contain forward-looking statements all of which are subject to market risks, and the possibility that the Company will not be able to achieve all of its stated goals. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.

SOURCE: Verisante Technology, Inc.



View the original press release on accesswire.com

Editor Details

Last Updated: 21-Dec-2023